UroToday.com

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

UroToday.com
Dec 19, 2024, 14:37 | Blog
ARANOTE Trial Implications for Metastatic Prostate Cancer Management - UroToday.com
UroToday.com shared a post on X: "Don't Miss!! ARANOTE trial implications for metastatic Prostate Cancer…
Dec 17, 2024, 23:36 | Blog
Durvalumab and chemotherapy improves survival in MIBC - Uro Today
UroToday.com shared  a post on X: "NIAGARA trial shows durvalumab + chemotherapy improves survival in…
Dec 16, 2024, 19:31 | Insight
RADIOSA Trial: SBRT vs SBRT and ADT for oligorecurrent Prostate Cancer - UroToday.com
UroToday.com shared a post on X: “RADIOSA Trial: SBRT vs SBRT and ADT for oligorecurrent…
Dec 16, 2024, 17:43 | Blog
UroToday.com - PARP inhibitors: Targeting DNA repair pathways in mCRPC
UroToday.com shared on X: "PARP inhibitors: Targeting DNA repair pathways. Neal Shore joins Fred Saad in…
Oct 1, 2024, 16:09 | Blog
Vedang Murthy presented results of the phase III BART trial at ASTRO24
Dr. Vedang Murthy, MD, is a Professor and Radiation Oncologist at Tata Memorial Hospital, Mumbai,…
Sep 7, 2024, 09:51 | Insight
Excellent exchange and discussion on urothelial carcinoma clinical trials
Sabine D. Brookman-May, Professor of Urology at the Ludwig-Maximilians University of Munchen, shared a post…
Jun 30, 2024, 14:00 | Blog
UroToday.com - Exploring imaging options and impact to treatment strategies in nmCPRC
UroToday.com shared on X: "Navigating the Nuances: Exploring imaging options and impact to treatment strategies in…
Jun 18, 2024, 17:53 | Blog
Sabine D. Brookman-May: Older patients with NMIBC show more aggressive tumors
Sabine D. Brookman-May, Professor of Urology at Ludwig-Maximilians University, shared a post by Niyati Lobo,  Consultant…
All: 8 Posts: 1 - 100
Special Coverage